BioMarin: Q4 Earnings Snapshot
By AP News
Published - Feb 27, 2023, 04:45 PM ET
Last Updated - Jun 22, 2023, 07:17 PM EDT
SAN RAFAEL, Calif. (AP) — SAN RAFAEL, Calif. (AP) — BioMarin Pharmaceutical Inc. (BMRN) on Monday reported a loss of $249,000 in its fourth quarter.
On a per-share basis, the San Rafael, California-based company said it had a loss of less than 1 cent. Earnings, adjusted for one-time gains and costs, came to 36 cents per share.
The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 39 cents per share.
The rare disease biopharmaceutical posted revenue of $537.5 million in the period, topping Street forecasts. Eleven analysts surveyed by Zacks expected $533.9 million.
